Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Clinuvel Pharmaceuticals (UR9A.STU) Q3 2026 Earnings
UR9A.STU
1
Sep
Confirmed
Q1 2026
0.12
0.13
0.15
0.17
Details
Expected EPS
0.31257249779999996
Actual EPS
N/A
Surprise EPS
-0.31
Surprise Percent
+100%
Description
Clinuvel Pharmaceuticals (UR9A.STU) will report earnings of for Q3 2026 on September 01, 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist